Skip to main content
. 2018 Jan 9;33(2):235–244. doi: 10.1007/s10654-017-0354-8

Table 3.

Hazard ratios and 95% confidence intervals for incident ischaemic heart disease, incident cerebrovascular disease and incident cardiovascular disease, by quintile of DASH accordance score; (EPIC-Norfolk cohort, n = 23,655)

Quintile of accordance to DASH Events per 100,000 person-years Model 1a Model 2b
Incident IHD
Q1 1262.2 1.00 (Ref.) 1.00 (Ref.)
Q2 1125.0 0.95 (0.86–1.05) 0.95 (0.86–1.05)
Q3 982.6 0.88* (0.79–0.99) 0.88* (0.78–0.99)
Q4 916.2 0.85** (0.76–0.95) 0.91 (0.81–1.01)
Q5 799.7 0.87* (0.77–0.99) 0.90 (0.79–1.02)
Incident stroke
Q1 422.0 1.00 (Ref.) 1.00 (Ref.)
Q2 376.9 0.93 (0.78–1.10) 0.95 (0.80–1.12)
Q3 323.3 0.84 (0.69–1.02) 0.85 (0.69–1.04)
Q4 320.5 0.84 (0.70–1.01) 0.87 (0.73–1.05)
Q5 261.3 0.79* (0.64–0.97) 0.80* (0.65–0.99)
Incident CVD
Q1 1471.7 1.00 (Ref.) 1.00 (Ref.)
Q2 1304.6 0.94 (0.86–1.03) 0.95 (0.87–1.04)
Q3 1154.2 0.88* (0.79–0.98) 0.89* (0.80–0.99)
Q4 1071.2 0.85** (0.77–0.94) 0.90* (0.81–0.99)
Q5 929.5 0.85** (0.76–0.95) 0.88* (0.79–0.99)

*p < 0.05; **p < 0.01;***p < 0.001

aAdjusted for age, sex and dietary energy

bAs Model 1 but further adjusted for smoking status, alcohol intake, physical activity, BMI, diabetes, SES, marital status, use of antihypertensive medication, use of lipid-lowering medication and history of CVD